Ernexa Therapeutics Inc.
ERNA | NASDAQ
$3.94
-$0.02 (-0.51%)
Sep 22, 2026, 10:53 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 1K | 488K | 535K | 582K | 598K | 162K | 115K | 68K | 51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 86K | 86K | n/a | n/a | -60K | 35K | 637K | 703K | 883K | 788K | 236K | 170K | 50K | 50K | n/a | 123K | 123K | 123K | 123K | n/a | n/a | n/a |
Gross Profit | -86K | -86K | n/a | 1K | 548K | 500K | -55K | -105K | -721K | -673K | -168K | -119K | -50K | -50K | n/a | -123K | -123K | -123K | -123K | n/a | n/a | n/a |
Operating Income | -11.74M | -10.13M | -9.32M | -9.92M | -10.19M | -12.62M | -15.67M | -18.74M | -21.99M | -21.61M | -21.14M | -20.11M | -22.91M | -32.24M | -33.22M | -37.02M | -114.99M | -111.12M | -113.75M | -107.42M | -23.15M | -15.15M |
Interest Income | 91K | 91K | 52K | 254K | 254K | 254K | 249K | n/a | n/a | 24K | 26K | 26K | 26K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.35M | -11.48M | -14.13M | -18.31M | -43.67M | -46.06M | -44.51M | -44.92M | -23.93M | -22.9M | -21.67M | -19.96M | -21.67M | -20.57M | -24.53M | -27.97M | -106.65M | -113.33M | -122.48M | -116.81M | -32.85M | -24.79M |
Net Income | -12.27M | -11.39M | -14.08M | -18.34M | -43.7M | -46.09M | -44.54M | -44.93M | -23.92M | -22.9M | -21.67M | -20M | -21.73M | -20.62M | -24.58M | -28.04M | -106.71M | -113.4M | -122.55M | -116.81M | -32.85M | -24.79M |
Selling & General & Admin | 5.32M | 5.37M | 5.16M | 5.28M | 7.71M | 10.24M | 12.59M | 15.56M | 16.16M | 14.85M | 14.67M | 13.86M | 13.22M | 16.06M | 16.98M | 17.45M | 18.34M | 17.49M | 14.6M | 10.99M | 7.84M | 4.3M |
Research & Development | 6.42M | 4.76M | 4.16M | 4.64M | 4.6M | 4.46M | 4.6M | 4.66M | 5.11M | 5.62M | 5.84M | 6.59M | 10.1M | 10.28M | 10.39M | 12.68M | 9.21M | 12.95M | 12.71M | 10.11M | 9.54M | 5.09M |
Other Expenses | -86K | -86K | n/a | n/a | -1.58M | -1.58M | -1.58M | -1.58M | n/a | 460K | 460K | -461K | -461K | 5.84M | 5.84M | 6.76M | 87.31M | 80.55M | 86.32M | 86.32M | 5.77M | 5.77M |
Operating Expenses | 11.65M | 10.05M | 9.32M | 9.92M | 10.74M | 13.12M | 15.62M | 18.64M | 21.27M | 20.93M | 20.97M | 19.99M | 22.86M | 32.19M | 33.22M | 36.89M | 114.86M | 111M | 113.62M | 107.42M | 23.15M | 15.15M |
Interest Expense | 86K | 31K | 31K | 3.51M | 5.17M | 5.97M | 6.75M | 3.66M | 2.09M | 1.29M | 502K | 120K | 16K | 29K | 30K | 42.03K | 52.03K | 61.03K | 74.03K | 67.52K | 60.08K | 38.08K |
Selling & Marketing Expenses | 6K | 6K | 6K | 6K | n/a | n/a | -541K | -541K | -541K | -541K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.63M | 10.13M | 9.32M | 9.92M | 10.68M | 13.15M | 16.26M | 19.34M | 22.15M | 21.72M | 21.2M | 20.16M | 22.91M | 32.24M | 33.22M | 37.02M | 114.99M | 111.12M | 113.75M | 107.42M | 23.15M | 15.15M |
Income Tax Expense | -88K | -93K | -45K | 28K | 34K | 34K | 30K | 15K | -5K | -4K | -3K | 41K | 54K | 50K | 45K | 69K | 64K | 64K | 64K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.18M | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.6K | 107.24K | 104.08K | 101.08K | 84.9K | 55.6K |
Shares Outstanding (Diluted) | 1.18M | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.61K | 107.25K | 104.08K | 101.08K | 84.9K | 55.6K |
EPS (Basic) | -18.85 | -30.70 | -27.50 | -33.25 | -152.50 | -162.75 | -189.75 | -207.75 | -110.50 | -106.25 | -102 | -99 | -135.50 | -54 | -143.75 | -199.50 | -988.50 | -1.17K | -1.37K | -1.33K | -501.50 | -407.25 |
EPS (Diluted) | -18.85 | -30.70 | -27.50 | -33.25 | -152.50 | -162.75 | -189.75 | -207.75 | -110.50 | -106.25 | -102 | -99 | -135.50 | -54 | -143.50 | -199.25 | -988.25 | -1.17K | -1.37K | -1.33K | -501.50 | -407.25 |
EBITDA | -17.56M | -16.54M | -19.2M | -14.59M | -37.86M | -38.93M | -36.12M | -39.07M | -19.59M | -19.46M | -19.49M | -18.7M | -20.91M | -20.12M | -24M | -27.4M | -106.06M | -112.77M | -121.95M | -116.38M | -32.52M | -24.57M |
EBIT | -13.63M | -16.76M | -19.41M | -14.8M | -38.5M | -40.09M | -37.76M | -41.12M | -21.7M | -21.06M | -20.62M | -19.43M | -21.24M | -20.54M | -24.5M | -27.93M | -106.6M | -113.27M | -122.41M | -116.74M | -32.79M | -24.74M |
Depreciation & Amortization | 172K | 227K | 210K | 209K | 643K | 1.17M | 1.64M | 2.05M | 2.12M | 1.6M | 1.12M | 728K | 332K | 421K | 497K | 534.4K | 537.4K | 502.4K | 459.4K | 361.09K | 262.36K | 170K |
Add to Watchlist
Select watchlists to add or remove ERNA